CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $865.00K in the quarter ending March 31, 2025, with 71.63% growth. This brings the company's revenue in the last twelve months to $37.68M, down -86.13% year-over-year. In the year 2024, CRISPR Therapeutics AG had annual revenue of $37.31M, down -89.95%.

• Revenue (ttm): $37.68M
• Revenue Growth: -86.13%
• P/S Ratio: 80.74
• Revenue / Employee: $95,865
• Employees: 393
• Market Cap: 3.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.31M	-333.89M	-89.95%
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%
Dec 31, 2020	719.00K	-288.87M	-99.75%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.